These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23050640)

  • 1. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke.
    Shichita T; Ago T; Kamouchi M; Kitazono T; Yoshimura A; Ooboshi H
    J Neurochem; 2012 Nov; 123 Suppl 2():29-38. PubMed ID: 23050640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-ischemic innate immunity and its application for novel therapeutic strategy targeting brain inflammation].
    Ito M; Kondo T; Shichita T; Yoshimura A
    Nihon Rinsho; 2013 Jul; 71(7):1291-301. PubMed ID: 23961683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ischemic inflammation in the brain.
    Shichita T; Sakaguchi R; Suzuki M; Yoshimura A
    Front Immunol; 2012; 3():132. PubMed ID: 22833743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.
    Vezzani A; Maroso M; Balosso S; Sanchez MA; Bartfai T
    Brain Behav Immun; 2011 Oct; 25(7):1281-9. PubMed ID: 21473909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DAMPs (damage-associated molecular patterns) and inflammation].
    Ooboshi H; Shichita T
    Nihon Rinsho; 2016 Apr; 74(4):573-8. PubMed ID: 27333742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke.
    Peterfalvi A; Molnar T; Banati M; Pusch G; Miko E; Bogar L; Pal J; Szereday L; Illes Z
    Cerebrovasc Dis; 2009; 28(5):490-8. PubMed ID: 19752550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
    Tsuyama J; Nakamura A; Ooboshi H; Yoshimura A; Shichita T
    Semin Immunopathol; 2018 Nov; 40(6):523-538. PubMed ID: 30206661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs).
    Franchini M; Zini E; Osto M; Jablonski K; Kaufmann K; Lutz TA; Reusch CE; Ackermann M
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):70-8. PubMed ID: 20674989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.
    Liu X; Zhan Z; Xu L; Ma F; Li D; Guo Z; Li N; Cao X
    J Immunol; 2010 Dec; 185(12):7244-51. PubMed ID: 21068402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
    Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
    Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
    Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
    J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
    Mukhopadhyay S; Peiser L; Gordon S
    J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity of the ocular surface.
    Ueta M; Kinoshita S
    Brain Res Bull; 2010 Feb; 81(2-3):219-28. PubMed ID: 19828129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
    Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.